41 studies found for:    Open Studies | "Candidiasis"
Show Display Options
Rank Status Study
21 Unknown  Anidulafungin Pharmacokinetics in Intensive Care Unit Patients
Conditions: Invasive Candidiasis;   Candidemia
Intervention:
22 Recruiting TOL-463 Phase 2 Study
Conditions: Vaginitis Bacterial;   Vulvovaginal Candidiasis
Intervention: Drug: TOL-463
23 Recruiting Immunological Interaction Between the Host and Candida Albicans Biofilm
Condition: Candidiasis
Intervention:
24 Unknown  Pre-hospital Risk Factors for Invasive Fungal Infection
Conditions: Acute Myeloid Leukemia;   Aspergillosis;   Candidiasis;   Mycoses
Intervention:
25 Recruiting Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis
Condition: Candidemia
Interventions: Drug: Anidulafungin;   Drug: Fluconazole
26 Recruiting Genetic Susceptibility Factors for Candidemia.
Conditions: Invasive Candidiasis;   Candidemia;   Genetic Predisposition to Disease
Intervention: Genetic: Analysis of genetic polymorphisms
27 Recruiting Variability of Fluconazole Concentration in Critically Ill Patients
Condition: Invasive Candidiasis
Intervention:
28 Recruiting BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia
Condition: Invasive Candidiasis
Intervention:
29 Recruiting Pharmacokinetics of Micafungin in Patients of Intensive Care Units
Condition: Invasive Candidiasis
Intervention: Other: micafungin
30 Recruiting Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation
Condition: Invasive Candidiasis
Intervention: Drug: Micafungin
31 Recruiting Rituximab for Anti-cytokine Autoantibody-Associated Diseases
Conditions: Anticytokine Autoantibody-Associated Diseases;   Disseminated Non-Tuberculous Mycobacteria;   Chronic Mucocutaneous Candidiasis;   Pulmonary Alveolar Proteinosis (PAP)
Intervention: Drug: Rituximab/Rituxan
32 Unknown  A Pilot Study for the Use of Biomarkers and Early Treatment of Invasive Candidiasis in Intensive Care Unit (ICU) Patients
Condition: Candidemia
Intervention: Drug: Anidulafungin
33 Unknown  Use of Oral Probiotics as an Adjunctive Therapy to Fluconazole in the Treatment of Yeast Vaginitis
Condition: Vaginal Candidiasis
Interventions: Drug: Probiotics (Natural product);   Drug: Probiotics (L. rhamnosus GR-1 and L. reuteri RC-14)
34 Unknown  Biliary Candidiasis - Optimization of Diagnostics and Therapy
Conditions: Secondary Cholangitis;   Bile Duct Strictures of Unknown Origin
Intervention: Procedure: ERCP
35 Not yet recruiting (1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in Sepsis
Conditions: Severe Sepsis;   Septic Shock
Interventions: Other: Standard of care;   Other: (1,3)-β-D-glucan guided therapy
36 Recruiting STRIVE: CD101 Compared to Caspofungin Followed by Oral Step Down Treatment in Subjects With Candidemia
Conditions: Candidemia;   Mycoses;   Fungal Infection;   Fungemia
Interventions: Drug: CD101 Injection;   Drug: Caspofungin;   Drug: Fluconazole;   Drug: intravenous placebo;   Drug: oral placebo
37 Recruiting Serial Therapeutic and Antifungal Monitoring Protocol
Condition: Candidemia
Intervention:
38 Unknown  Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia
Condition: Candidemia
Intervention: Drug: Interferon-gamma, Recombinant
39 Unknown  Risk Factor and Outcome of Candidemia
Condition: Candidemia
Intervention:
40 Unknown  The Relationship Between Morphology and Virulent Genes of Candida Albicans and Clinical Aspects, Surveillance of Fungemia
Condition: Candidemia Prognostic Factor and Mycobiological Analysis.
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results    Last Page
Indicates status has not been verified in more than two years